PANAMA CITY, April 22, 2025 /PRNewswire/ -- BingX, a global leading cryptocurrency exchange, kicks off its 7th anniversary as a Platinum Sponsor at TOKEN2049 Dubai. This premier Web3 gathering marks the beginning of a global series of festivities commemorating BingX's milestone. As the anniversary unfolds, BingX will continue its celebration with a lineup of offline events around the world, uniting users, partners, and communities in a shared journey of growth and gratitude.
Attendees at the TOKEN2049 conference will be able to enjoy the vibrant anniversary spirit that infuses the event experience. The celebratory atmosphere, from immersive booth interactions to BingX-branded boats adorning the waterfront, highlights the connections BingX has built with its global user base. Attendees will also have the opportunity to meet BingX's core team, provide feedback, and discover the strategy and innovation behind the platform's latest product developments. In addition, BingX will host a private side event, bringing together key partners, traders, and community members for a meaningful evening of connection and reflection.
"We are proud to mark our 7th anniversary with meaningful moments alongside our global community," said Vivien Lin, Chief Product Officer of BingX. "Dubai is one of the many ideal places to celebrate how far we've come — not just as a platform, but as a user-first brand. From our early days to now being a top 5 derivative platform, our journey has been shaped by every user, every conversation, and the stories they tell. By showing up at TOKEN2049 as a major sponsor, we are reinforcing our belief that innovation starts with us listening."
BingX's celebration is already well underway. The "Your Voice, Our Story" Campaign invited users to share their personal journeys with BingX, shining a light on the very community that helped shape the platform. Chelsea FC and BingX also teamed up to launch the Bitcoin Fantasy 7 campaign, giving fans the chance to build their dream team and win exclusive prizes. Coming up next is a global trading campaign featuring various competitions, community rewards, and special giveaways as well. Together, activities reflect BingX's commitment to creating fun, rewarding experiences that strengthen its connection with users worldwide
About BingX
Founded in 2018, BingX is a leading crypto exchange, serving over 20 million users worldwide. BingX offers diversified products and services, including spot, derivatives, copy trading, and asset management – all designed for the evolving needs of users, from beginners to professionals. BingX is committed to providing a trustworthy platform that empowers users with innovative tools and features to elevate their trading proficiency. In 2024, BingX proudly became the official crypto exchange partner of Chelsea Football Club, marking an exciting debut in the world of sports.
For more information please visit: https://bingx.com/
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
BingX Marks 7 Years with Grand Celebrations at TOKEN2049 Dubai
HONG KONG, May 1, 2025 /PRNewswire/ -- An international consortium led by The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) and the University of Calgary in Canada has conducted a global epidemiological study on Inflammatory Bowel Disease (IBD). It found that this chronic gut condition follows a four-stage epidemiological evolution across different regions of the world. Analysing data from more than 500 epidemiological studies across 80 regions in the past century, the team generated a machine-learning model for classification of stages which enables health-care systems to prepare for the growing burden on healthcare arising from the prevalence of IBD. Results of the study have been published in the leading scientific journal Nature.
Epidemiological model informs trend of IBD burden for the next 20 years
The Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES‑21) consortium, led by Professor Gilaad Kaplan of University of Calgary and Professor Siew Ng of CU Medicine, synthesised data from 522 population-based studies across 82 geographical regions over the past century. They observed differences in IBD incidence and prevalence across various geographical areas over the past century suggest that epidemiological patterns shift through time.
To further explore the trends and characterise the epidemiology of IBD independent of geography and time, researchers developed a machine-learning model that classifies regions by epidemiologic stage, maps spatiotemporal transitions across stages and models a theoretical prevalence stage for the next two decades. They also demonstrated a stage where IBD prevalence reaches equilibrium. (Please refer to Table 1 for details.)
Professor Gilaad Kaplan, Professor of Medicine at the Cumming School of Medicine, the University of Calgary, said: "Our analysis, drawing on a century's worth of historical epidemiologic data, enables health authorities to tailor interventions – whether clinical, policy driven or preventive."
Incidence rapidly rising in China and Malaysia while Japan and South Korea seeing an acceleration in prevalence
Study data showed epidemiological stages vary among regions in Asia. Japan and South Korea, which underwent rapid industrialisation in the latter half of the 20th century, have reported prevalence exceeding 0.1%, placing them on the brink of transitioning towards stage 3. In contrast, nations like China and Malaysia, which industrialised later, entered stage 2 more recently.
Dr Joyce Mak, Honorary Clinical Associate Professor in the Department of Medicine and Therapeutics at CU Medicine, said: "Today, we stand at a critical juncture as we address the alarming rise in IBD in newly industrialised countries such as China and Malaysia. This increase is not just a statistic; it represents the health and well-being of millions of people. As these nations embrace rapid industrialisation and urbanisation, we must prioritise public health initiatives, enhance awareness, and invest in research to understand underlying causes of this disease."
Professor Siew Ng, Croucher Professor in Medical Sciences at CU Medicine, Director of the Microbiota I-Center (MagIC) and New Cornerstone Investigator, said: "Our GIVES‑21 consortium is conducting epidemiologic surveillance studies in low- and middle-income countries, as the disease is evolving in these regions. We are seeing a paradigm shift of IBD accelerating in these regions and we will need to prepare our clinical infrastructure and personnel to manage this complex and costly disease. We are planning research to focus on preventive strategies targeting the gut microbiome, diet and environmental exposures to reduce disease incidence."
This study was supported by The Leona M. and Harry B. Helmsley Charitable Trust, the International Organization for the study of IBD (IOIBD), and contributions from over 30 international partners.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
A global study led by CUHK and the University of Calgary charts four-stage evolution of Inflammatory Bowel Disease
